Variable | Relapse-free survival | Overall survival | ||
---|---|---|---|---|
HR (95% CI) | P valued | HR (95% CI) | P valued | |
Age (> 65 vs. ≤ 65 years) | 1.22 (0.68–2.18) | 0.508 | 1.78 (0.86–3.72) | 0.123 |
Primary tumor site (left vs. right) | 1.36 (0.81–2.29) | 0.244 | 0.75 (0.39–1.43) | 0.382 |
Tumor grade (G3 vs. G1–2) | 0.99 (0.79–1.24) | 0.937 | 0.85 (0.63–1.15) | 0.290 |
pT category (pT3–4 vs. pT1–2) | 1.07 (0.55–2.10) | 0.843 | 1.28 (0.47–3.49) | 0.624 |
pN category (pN1–2 vs. pN0) | 1.06 (0.70–1.61) | 0.775 | 1.16 (0.66–2.04) | 0.617 |
Preoperative CEA level (> 5 vs. ≤ 5 ng/mL) | 0.83 (0.55–1.25) | 0.380 | 1.43 (0.81–2.50) | 0.216 |
Interval from primary tumor resection to liver metastases (> 12 vs. ≤ 12 months) | 0.96 (0.55–1.68) | 0.881 | 1.18 (0.58–2.40) | 0.649 |
Number of metastases (> 1 vs. 1 per patient) | 0.96 (0.58–1.60) | 0.883 | 0.87 (0.44–1.75) | 0.703 |
Maximum size of metastases (> 5 vs. ≤ 5 cm) | 0.82 (0.48–1.41) | 0.482 | 1.48 (0.81–2.71) | 0.199 |
Resection status (R1–2 vs. R0) | 2.27 (1.45–3.56) | < 0.001 | 2.00 (1.13–3.54) | 0.017 |
Radiologic response (SD/PD vs. PR)a | 0.75 (0.49–1.15) | 0.184 | 1.23 (0.67–2.25) | 0.497 |
Duration of preoperative chemotherapy (long vs. short)b | 1.28 (0.86–1.91) | 0.231 | 0.81 (0.46–1.41) | 0.451 |
Chemotherapy backbone (CT with Bev vs. CT only) | 1.33 (0.74–2.39) | 0.340 | 1.33 (0.61–2.92) | 0.472 |
Chemotherapy backbone (CT with Cet vs. CT only) | 1.24 (0.70–2.22) | 0.458 | 1.68 (0.82–3.42) | 0.153 |
Postoperative chemotherapy (yes vs. no) | 0.50 (0.33–0.76) | 0.001 | 0.50 (0.28–0.90) | 0.021 |
TRG (TRG4–5 vs. TRG1–3)c | 1.71 (1.15–2.56) | 0.008 | 1.71 (1.02–2.88) | 0.041 |